National Vision Holdings Spotlights LACRIFILL® at ASCRS for Transformative Eye Care Solutions

Transformative Eye Care: Nordic Pharma's LACRIFILL® Takes Center Stage at ASCRS

Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., is poised to make a significant impact at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in Los Angeles. From April 25-28, 2025, the company will present new patient data and findings from a recent patient experience study regarding its innovative product, LACRIFILL® Canalicular Gel. This treatment, designed to alleviate symptoms of dry eye, is gaining traction in the ophthalmic community due to its promising efficacy and strong patient satisfaction rates.

Recent research, highlighted in the April issue of Cataract & Refractive Surgery Today, showcases a case study conducted by Dr. Neel Desai and Dr. Subhashini Chandrasekaran. Their findings indicate that lacrimal occlusion with LACRIFILL not only improves visual acuity but also enhances optical quality for patients experiencing fluctuating vision following cataract surgery. The study serves as a testament to the gel's effectiveness and positions LACRIFILL as a valuable addition to post-operative care protocols. Additionally, a Patient Experience survey featured in the May issue of the same publication reveals that an impressive 98.11% of patients would choose to receive another dose of LACRIFILL, underscoring its strong acceptance and positive reception among users.

Jai Parekh, Chief Commercial Officer of Eye Care U.S., expresses enthusiasm about sharing these impactful results with attendees at ASCRS. He emphasizes the transformative potential of LACRIFILL in enhancing patient care and improving outcomes for individuals suffering from dry eye symptoms. Dr. Priya Mathews, another participant at the event, is eager to engage in discussions regarding the practical benefits of integrating LACRIFILL into clinical practice. The conference not only serves as a platform for showcasing cutting-edge advancements in eye care but also allows Nordic Pharma to connect with healthcare professionals dedicated to improving patient experiences.

In a commendable gesture, Nordic Pharma will also use its presence at the ASCRS meeting to honor the bravery of firefighters who battled the recent California wildfires. The company plans to set up a donation booth (#717) featuring a QR code for contributions to the Los Angeles Fire Department Foundation, which Nordic Group B.V. will match, amplifying the impact of donations. This initiative reflects the company’s commitment to corporate social responsibility and community support alongside its dedication to advancing ophthalmic treatments.

For those interested in LACRIFILL Canalicular Gel, further information is available at lacrifill.com, where healthcare providers and patients can access resources about this innovative treatment.